News
Cirrus Logic Q1 Earnings Call Highlights
Key Points
- Interested in Cirrus Logic, Inc.? Here are five stocks we like better.
- Record quarterly performance: Cirrus Logic reported fiscal Q1 revenue of $460 million, up 13% year over year
Clover Health Investments Q2 Earnings Call Highlights
Key Points
- Interested in Clover Health Investments, Corp.? Here are five stocks we like better.
- Clover Health reported strong second-quarter results: Medicare Advantage membership rose 48%
Carlsmed Q2 Earnings Call Highlights
Key Points
- Interested in Carlsmed, Inc.? Here are five stocks we like better.
- Carlsmed’s Q2 revenue rose 57% year over year to $18.9 million, driven by higher adoption of its aprevo lumbar
Axon Enterprise Q2 Earnings Call Highlights
Key Points
- Interested in Axon Enterprise, Inc? Here are five stocks we like better.
- Axon reported strong Q2 growth: Revenue rose 35% year over year to $904 million, prompting the company to
Chemours Q2 Earnings Call Highlights
Key Points
- Interested in The Chemours Company? Here are five stocks we like better.
- Second-quarter performance exceeded profit expectations despite sales falling slightly short, as pricing
Brink's Q2 Earnings Call Highlights
Key Points
- Interested in Brink's Company (The)? Here are five stocks we like better.
- Brink’s delivered strong Q2 results, with 4% organic revenue growth, 11% adjusted EBITDA growth to $257
Assurant Q2 Earnings Call Highlights
Key Points
- Interested in Assurant, Inc.? Here are five stocks we like better.
- Assurant reported a second consecutive quarter of record earnings, with first-half adjusted EBITDA up 12% and
Adient Q3 Earnings Call Highlights
Key Points
- Interested in Adient? Here are five stocks we like better.
- Q3 revenue rose 5% to approximately $3.9 billion, but adjusted EBITDA remained flat at $225 million as Middle East-related
Trivago N.V. ADS Q2 Earnings Call Highlights
Key Points
- Interested in Trivago N.V. ADS? Here are five stocks we like better.
- Trivago reported strong Q2 results: Revenue rose 21% year over year to €168.4 million, adjusted EBITDA turned
Trinity Capital Q2 Earnings Call Highlights
Key Points
- Interested in Trinity Capital Inc.? Here are five stocks we like better.
- Record growth: Trinity Capital funded $619 million in the second quarter, up 69% year over year, while total
Eutelsat Aktie: Hanwha testet OneWeb in Busan
Die südkoreanische Marine (RoKN) und der Rüstungskonzern Hanwha Systems haben am Montag ein großangelegtes…
Der Beitrag Eutelsat Aktie: Hanwha testet OneWeb in Busan erschien zuerst auf kapitalmarkt
Insulet Q2 Earnings Call Highlights
Key Points
- Interested in Insulet Corporation? Here are five stocks we like better.
- Strong Q2 performance: Insulet reported revenue of $802 million, up 22.7% on a constant-currency basis, while
BeOne Medicines Q2 Earnings Call Highlights
Key Points
- Interested in BeOne Medicines Ltd. - Sponsored ADR? Here are five stocks we like better.
- Strong second-quarter performance: BeOne Medicines reported revenue of $1.7 billion, up 30%
Orion Energy Systems Q1 Earnings Call Highlights
Key Points
- Interested in Orion Energy Systems, Inc.? Here are five stocks we like better.
- Strong first-quarter performance: Revenue increased 32% year over year to $25.7 million, while net
NiCE Q2 Earnings Call Highlights
Key Points
- Interested in NiCE? Here are five stocks we like better.
- Second-quarter performance exceeded expectations: Revenue rose 8% year over year to $782 million, and adjusted EPS reached
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
Key Points
- Interested in NewAmsterdam Pharma Company N.V.? Here are five stocks we like better.
- PREVAIL is the key near-term catalyst: NewAmsterdam expects to reach its interim event target by
LivaNova Q2 Earnings Call Highlights
Key Points
- Interested in LivaNova PLC? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 9.8% year over year on a constant-currency basis to $391 million, while adjusted
Kymera Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Kymera Therapeutics, Inc.? Here are five stocks we like better.
- KT-621 atopic dermatitis trial enrollment is complete about six months ahead of schedule, with top-line
Interparfums Q2 Earnings Call Highlights
Key Points
- Interested in Interparfums, Inc.? Here are five stocks we like better.
- Interparfums maintained its 2026 outlook for approximately $1.48 billion in sales and diluted EPS of $4.85
Avnet Q4 Earnings Call Highlights
Key Points
- Interested in Avnet, Inc.? Here are five stocks we like better.
- Record fourth-quarter results: Avnet reported fiscal 2026 Q4 sales of $8.3 billion, up 48% year over year, and
Innospec Q2 Earnings Call Highlights
Key Points
- Interested in Innospec Inc.? Here are five stocks we like better.
- Strong second-quarter results: Revenue increased 12% to $491.4 million and net income rose to $30.8 million, with
Greenlight Capital Re Q2 Earnings Call Highlights
Key Points
- Interested in Greenlight Capital Re, Ltd.? Here are five stocks we like better.
- Greenlight Re posted a $29.6 million second-quarter net loss, or $0.89 per diluted share, as a $23.8
Criteo Q2 Earnings Call Highlights
Key Points
- Interested in Criteo S.A.? Here are five stocks we like better.
- Criteo lowered its 2026 outlook after second-quarter results missed expectations, primarily because several large
Thyssenkrupp Aktie: Entscheidet die HV am Freitag über den Wert von tk accelis?
Thyssenkrupp steht vor einer der wichtigsten Weichenstellungen der jüngeren Konzerngeschichte. Am Freitag stimmen die…
Der Beitrag Thyssenkrupp Aktie: Entscheidet die HV am Freitag über den Wert von
1stdibs.com Q2 Earnings Call Highlights
Key Points
- Interested in 1stdibs.com, Inc.? Here are five stocks we like better.
- Q2 results exceeded guidance: GMV rose 7% year over year to $96 million and revenue increased 5% to $23.3